test

Troy Wuertz

@Ikarian Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$717.154MTotal holdings121
Assets growth rate24.93%Assets growth rate (2-Q avg)-6.06%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Ikarian Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 121 positions.

Assets under management

The assets under management (AUM) of Ikarian Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 717.154M in assets, with a quarterly growth rate of 24.93% and a 2-quarter average growth rate of -6.06%. The portfolio is managed by Troy Wuertz, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
VRTXVertex Pharmaceuticals Inc
Recent Activity
New Position
12.98%
$93.016M↓ Put
200,000 shares@ $465.08 avg price
AMGNAmgen Inc
Recent Activity
Increased 309.52%
7.16%
$51.328M↑ Call
159,300 shares@ $322.22 avg price
XBISpdr Ser Tr
Recent Activity
New Position
6.89%
$49.4M↓ Put
500,000 shares@ $98.8 avg price
TARSTarsus Pharmaceuticals Inc
Recent Activity
Increased 28.75%
4.73%
$33.886M
1.03M shares@ $32.9 avg price
ANABAnaptysbio Inc
Recent Activity
New Position
3.53%
$25.269M↓ Put
754,300 shares@ $33.5 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
Decreased -27.49%
3.05%
$21.815M
426,913 shares@ $51.11 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
New Position
2.9%
$20.768M↓ Put
611,000 shares@ $33.99 avg price
SLNOSoleno Therapeutics Inc
Recent Activity
Decreased -25.59%
2.34%
$16.734M↑ Call
331,437 shares@ $50.5 avg price
JANXJanux Therapeutics Inc
Recent Activity
New Position
2.32%
$16.591M↓ Put
365,200 shares@ $45.43 avg price
BHVNBiohaven Ltd
Recent Activity
New Position
2.27%
$16.27M↓ Put
325,600 shares@ $49.97 avg price